Description
A recent study demonstrated the efficacy of an enhanced anti-infection prophylaxis strategy, including piperacillin/tazobactam, in reducing surgical site infections following pancreatoduodenectomy. These findings highlight the importance of tailored antibiotic regimens to improve patient outcomes and optimize healthcare resource allocation.